AL
DRNA

Airain Ltd’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Airain Ltd’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,376
Closed -$173K – 1129
2015
Q2 		$173K Buy
+12,376
New +$227K 0.01% 774
2015
Q1 		– Sell
-10,500
Closed -$173K – 1009
2014
Q4 		$173K Buy
+10,500
New +$121K 0.01% 608

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Airain Ltd's DRNA Position: Q3 2015 in Review

Airain Ltd sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2015, closing a stake of 12,376 shares — an estimated $173K sold.

Airain Ltd first reported a position in DRNA in Q4 2014 and held it in 2 quarters. The position peaked at $173K in Q2 2015. 51 funds tracked by Wall St. Rank hold DRNA as of Q3 2015.

  • Airain Ltd reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Airain Ltd sold 12,376 Dicerna Pharmaceuticals, Inc. shares in Q3 2015, an estimated $173K.
  • Airain Ltd first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
  • Airain Ltd's Dicerna Pharmaceuticals, Inc. position peaked at $173K in Q2 2015.
  • 51 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.